Skip to main content
Top
Published in: Journal of Neurology 1/2014

01-01-2014 | Original Communication

Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson’s disease?

Authors: Daniel Guidez, Stefanie Behnke, Ramona Halmer, Ulrich Dillmann, Klaus Faßbender, Carl M. Kirsch, Dirk Hellwig, Jörg Spiegel

Published in: Journal of Neurology | Issue 1/2014

Login to get access

Abstract

Patients with idiopathic Parkinson’s disease (IPD) have a reduced myocardial MIBG uptake in MIBG scintigraphy, indicating myocardial sympathetic denervation. We were interested whether this myocardial sympathetic denervation coincides with clinical symptoms of autonomic impairment in IPD patients. We performed MIBG scintigraphy, the SCOPA-AUT scale, a standardized medical history (developed in our clinic) and autonomic nervous system testing in 47 IPD patients (21 female, 26 male patients). We correlated myocardial MIBG uptake with the results of the SCOPA-AUT scale, the standardized medical history and the autonomic nervous system testing through the use of Spearman’s correlation. Myocardial MIBG uptake correlated significantly (p < 0.05) with several items of the SCOPA-AUT scale (in female patients: perspiration during the night, in male patients: sum score, saliva dribbling of the mouth, difficulty swallowing, fainting, constipation), of the standardized medical history (in male patients: swollen ankles) and of the autonomic nervous system testing (all patients: sum score, Ewing orthostasis test). Remarkably, we found more significant correlations in male than in female patients. Reduced myocardial sympathetic innervation—as revealed by MIBG scintigraphy—is associated with clinical symptoms of autonomic impairment. This association is more pronounced in male than in female patients. The cause for this gender-specific phenomenon is unclear.
Literature
1.
go back to reference Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11:351–355CrossRefPubMed Braune S (2001) The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes. Clin Auton Res 11:351–355CrossRefPubMed
2.
go back to reference Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M et al (1995) A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 53:230–234CrossRefPubMed Hirayama M, Hakusui S, Koike Y, Ito K, Kato T, Ikeda M et al (1995) A scintigraphical qualitative analysis of peripheral vascular sympathetic function with meta-[123I]iodobenzylguanidine in neurological patients with autonomic failure. J Auton Nerv Syst 53:230–234CrossRefPubMed
3.
go back to reference Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:249–251PubMedCentralCrossRefPubMed Nagayama H, Hamamoto M, Ueda M, Nagashima J, Katayama Y (2005) Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson’s disease. J Neurol Neurosurg Psychiatry 76:249–251PubMedCentralCrossRefPubMed
4.
go back to reference Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194PubMedCentralCrossRefPubMed Orimo S, Ozawa E, Nakade S, Sugimoto T, Mizusawa H (1999) (123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson’s disease. J Neurol Neurosurg Psychiatry 67:189–194PubMedCentralCrossRefPubMed
5.
go back to reference Satoh A, Serita T, Tsujihata M (1997) Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson’s disease: assessment of cardiac sympathetic denervation. Nihon Rinsho 55:202–206PubMed Satoh A, Serita T, Tsujihata M (1997) Total defect of metaiodobenzylguanidine (MIBG) imaging on heart in Parkinson’s disease: assessment of cardiac sympathetic denervation. Nihon Rinsho 55:202–206PubMed
6.
go back to reference Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R et al (2009) Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 16:174–182CrossRefPubMed Sawada H, Oeda T, Yamamoto K, Kitagawa N, Mizuta E, Hosokawa R et al (2009) Diagnostic accuracy of cardiac metaiodobenzylguanidine scintigraphy in Parkinson disease. Eur J Neurol 16:174–182CrossRefPubMed
7.
go back to reference Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord 22:1004–1008CrossRefPubMed Spiegel J, Hellwig D, Farmakis G, Jost WH, Samnick S, Fassbender K et al (2007) Myocardial sympathetic degeneration correlates with clinical phenotype of Parkinson’s disease. Mov Disord 22:1004–1008CrossRefPubMed
8.
go back to reference Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M et al (2000) Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566–573CrossRefPubMed Taki J, Nakajima K, Hwang EH, Matsunari I, Komai K, Yoshita M et al (2000) Peripheral sympathetic dysfunction in patients with Parkinson’s disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 27:566–573CrossRefPubMed
9.
go back to reference Yoshita M (1998) Differentiation of idiopathic Parkinson’s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60–67CrossRefPubMed Yoshita M (1998) Differentiation of idiopathic Parkinson’s disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 155:60–67CrossRefPubMed
10.
go back to reference Leńska-Mieciek M, Derecka-Charzyńska I, Fiszer U, Królicki L, Kułakowski P (2011) Syncope and autonomic cardiovascular dysfunction in Parkinson disease. Neurol Neurochir Pol 45:335–341PubMed Leńska-Mieciek M, Derecka-Charzyńska I, Fiszer U, Królicki L, Kułakowski P (2011) Syncope and autonomic cardiovascular dysfunction in Parkinson disease. Neurol Neurochir Pol 45:335–341PubMed
11.
go back to reference Manabe Y, Fujii D, Kono S, Sakai Y, Tanaka T, Narai H (2011) Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson’s disease. J Neurol Sci 307:153–156CrossRefPubMed Manabe Y, Fujii D, Kono S, Sakai Y, Tanaka T, Narai H (2011) Systemic blood pressure profile correlates with cardiac 123I-MIBG uptake in patients with Parkinson’s disease. J Neurol Sci 307:153–156CrossRefPubMed
12.
go back to reference Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease. J Neurol 257:969–976CrossRefPubMed Oka H, Toyoda C, Yogo M, Mochio S (2010) Olfactory dysfunction and cardiovascular dysautonomia in Parkinson’s disease. J Neurol 257:969–976CrossRefPubMed
13.
go back to reference Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25:1183–1189CrossRefPubMed Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25:1183–1189CrossRefPubMed
14.
go back to reference Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Disord 26:1869–1874CrossRefPubMed Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Disord 26:1869–1874CrossRefPubMed
15.
go back to reference Haensch CA, Lerch H, Jörg J, Isenmann S (2009) Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson’s disease. Parkinsonism Relat Disord 15:134–137CrossRefPubMed Haensch CA, Lerch H, Jörg J, Isenmann S (2009) Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson’s disease. Parkinsonism Relat Disord 15:134–137CrossRefPubMed
16.
go back to reference Berganzo K, Tijero B, Somme JH, Llorens V, Sánchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonism’s and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18:45–48CrossRefPubMed Berganzo K, Tijero B, Somme JH, Llorens V, Sánchez-Manso JC, Low D et al (2012) SCOPA-AUT scale in different parkinsonism’s and its correlation with (123) I-MIBG cardiac scintigraphy. Parkinsonism Relat Disord 18:45–48CrossRefPubMed
17.
go back to reference Visser M, Marinus J, Stiggelbout AM, van Hilton JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRefPubMed Visser M, Marinus J, Stiggelbout AM, van Hilton JJ (2004) Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 19:1306–1312CrossRefPubMed
18.
go back to reference Hughes A, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed Hughes A, Daniel SE, Kilford L, Lees AJ (1992) Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55:181–184PubMedCentralCrossRefPubMed
19.
go back to reference Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293PubMedCentralCrossRefPubMed Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P et al (2010) Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 33:2285–2293PubMedCentralCrossRefPubMed
20.
go back to reference Kim JS, Shim YS, Song IU, Yoo JY, Kim HT, Kim YI et al (2009) Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson’s disease. Parkinsonism Relat Disord 15:706–708CrossRefPubMed Kim JS, Shim YS, Song IU, Yoo JY, Kim HT, Kim YI et al (2009) Cardiac sympathetic denervation and its association with cognitive deficits in Parkinson’s disease. Parkinsonism Relat Disord 15:706–708CrossRefPubMed
21.
go back to reference Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2008) Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson’s disease. J Neurol Sci 264:22–26CrossRefPubMed Kitayama M, Wada-Isoe K, Irizawa Y, Nakashima K (2008) Association of visual hallucinations with reduction of MIBG cardiac uptake in Parkinson’s disease. J Neurol Sci 264:22–26CrossRefPubMed
22.
go back to reference Kashihara K, Ohno M, Katsu Y (2005) Psychoses in patients with Parkinson’s disease; their frequency, phenomenology, and clinical correlates. Rinsho Shinkeigaku 45:1–5PubMed Kashihara K, Ohno M, Katsu Y (2005) Psychoses in patients with Parkinson’s disease; their frequency, phenomenology, and clinical correlates. Rinsho Shinkeigaku 45:1–5PubMed
23.
go back to reference Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M et al (2007) Impaired cardiovascular autonomic function in Parkinson’s disease with visual hallucinations. Mov Disord 22:1510–1514CrossRefPubMed Oka H, Yoshioka M, Onouchi K, Morita M, Mochio S, Suzuki M et al (2007) Impaired cardiovascular autonomic function in Parkinson’s disease with visual hallucinations. Mov Disord 22:1510–1514CrossRefPubMed
24.
go back to reference Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T et al (2010) Relationship between (123)I-MIBG scintigrams and REM sleep behaviour disorder in Parkinson’s disease. Parkinsonism Relat Disord 16:683–685CrossRefPubMed Nomura T, Inoue Y, Högl B, Uemura Y, Kitayama M, Abe T et al (2010) Relationship between (123)I-MIBG scintigrams and REM sleep behaviour disorder in Parkinson’s disease. Parkinsonism Relat Disord 16:683–685CrossRefPubMed
25.
go back to reference Kim JS, Lee KS, Song IU, Kim YI, Kim SH, You IR et al (2008) Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci 270:122–126CrossRefPubMed Kim JS, Lee KS, Song IU, Kim YI, Kim SH, You IR et al (2008) Cardiac sympathetic denervation is correlated with Parkinsonian midline motor symptoms. J Neurol Sci 270:122–126CrossRefPubMed
26.
go back to reference Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M et al (2004) Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220:105–111CrossRefPubMed Saiki S, Hirose G, Sakai K, Kataoka S, Hori A, Saiki M et al (2004) Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD. J Neurol Sci 220:105–111CrossRefPubMed
27.
go back to reference Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F (2006) Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease correlate with major autonomic symptoms? Parkinsonism Relat Disord 12:284–288CrossRefPubMed Matsui H, Nishinaka K, Oda M, Komatsu K, Kubori T, Udaka F (2006) Does cardiac metaiodobenzylguanidine (MIBG) uptake in Parkinson’s disease correlate with major autonomic symptoms? Parkinsonism Relat Disord 12:284–288CrossRefPubMed
28.
go back to reference Oka H, Toyoda C, Yogo M, Mochio S (2011) Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson’s disease. J Neural Transm 118:1323–1327CrossRefPubMed Oka H, Toyoda C, Yogo M, Mochio S (2011) Reduced cardiac 123I-MIBG uptake reflects cardiac sympathetic dysfunction in de novo Parkinson’s disease. J Neural Transm 118:1323–1327CrossRefPubMed
29.
go back to reference Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N (2009) Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson’s disease. J Neurol Sci 276:79–83CrossRefPubMed Shibata M, Morita Y, Shimizu T, Takahashi K, Suzuki N (2009) Cardiac parasympathetic dysfunction concurrent with cardiac sympathetic denervation in Parkinson’s disease. J Neurol Sci 276:79–83CrossRefPubMed
Metadata
Title
Is reduced myocardial sympathetic innervation associated with clinical symptoms of autonomic impairment in idiopathic Parkinson’s disease?
Authors
Daniel Guidez
Stefanie Behnke
Ramona Halmer
Ulrich Dillmann
Klaus Faßbender
Carl M. Kirsch
Dirk Hellwig
Jörg Spiegel
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 1/2014
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-013-7135-4

Other articles of this Issue 1/2014

Journal of Neurology 1/2014 Go to the issue